Solid Biosciences Inc.SLDBNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank30
3Y CAGR-27.2%
5Y CAGR-17.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-27.2%/yr
vs +15.8%/yr prior
5Y CAGR
-17.3%/yr
Recent deceleration
Acceleration
-43.0pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $59.90M | -25.3% |
| 2024 | $80.23M | +8.4% |
| 2023 | $74.02M | -52.4% |
| 2022 | $155.38M | +30.4% |
| 2021 | $119.14M | -23.0% |
| 2020 | $154.74M | +103.5% |
| 2019 | $76.04M | -12.0% |
| 2018 | $86.37M | +65.8% |
| 2017 | $52.08M | +578.3% |
| 2016 | $7.68M | - |